Skip to content
Search for:
HOME
ABOUT
History
Why
Mission
Organization
Board, Scientific Advisory Committee & Scientific Advisory Board
Partners
PROGRAMS
The First 1000 Days, the first line of prevention
Nutrition & Development
Age-Related Hearing Loss (ARHL)
Vaccination & HPV
IAS – International Atherosclerosis Society
WORKING WITH
Advisory
Content Development & Publishing
Interdisciplinary & International Panels
Partnerships
Community & Country Campaigns
Bespoke Development Projects
SUCCESS STORIES
PUBLICATIONS
Publications 2015 –
Past Publications 2011 – 2014
Past Publications 1991 – 2010
SLIDE LIBRARIES
EVENTS
Events 2015 –
Past Events 2000 – 2014
Past Events 1970 – 1999
NEWS
SUPPORTERS
CONTACT
Past Publications 2011 – 2014
Past Publications 2011 – 2014
Gianpaolo Bagnato
2021-01-26T09:29:27+00:00
2014
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology - Clin Chem Lab Med 2014
Hearing Loss and Dementia in the Aging Population - Audiol Neurotol 2014;19(suppl 1):6–9 DOI: 10.1159/000371595
LA VACCINAZIONE ANTI-HPV UNIVERSALE
valore sanitario, sociale
ed economico a supporto delle decisioni
di sanità pubblica (Dicembre 2014)
Mini Review “Hearing loss and cognitive decline in older adults: questions and answers” (2014)
Copeptin in critical illness (2014)
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology (2014)
2013
Towards the eradication of HPV infection through universal specific vaccination (2013)
2012
Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine (2012)
La vaccinazione contro HPV un passo avanti nel ridurre diseguaglianze nella società - Il Sole 24 Ore Sanità - 11 Dicembre 2012
Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin (2012)
Share This Story, Choose Your Platform!
Page load link
Go to Top
